[go: up one dir, main page]

CN111973709A - Broad-spectrum plant composition for curing and radically treating liver cancer and preparation method thereof - Google Patents

Broad-spectrum plant composition for curing and radically treating liver cancer and preparation method thereof Download PDF

Info

Publication number
CN111973709A
CN111973709A CN202010910278.8A CN202010910278A CN111973709A CN 111973709 A CN111973709 A CN 111973709A CN 202010910278 A CN202010910278 A CN 202010910278A CN 111973709 A CN111973709 A CN 111973709A
Authority
CN
China
Prior art keywords
parts
alkaloid
volatile oil
liver cancer
curing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010910278.8A
Other languages
Chinese (zh)
Inventor
陈爱红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010910278.8A priority Critical patent/CN111973709A/en
Publication of CN111973709A publication Critical patent/CN111973709A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/264—Aristolochia (Dutchman's pipe)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285—Aucklandia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/342—Adenophora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/487—Psoralea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536—Prunella or Brunella (selfheal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888—Pinellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968—Ophiopogon (Lilyturf)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9062—Alpinia, e.g. red ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a broad-spectrum plant composition for curing and radically treating liver cancer and a preparation method thereof, wherein the composition comprises the following components in parts by weight: 38-68 parts of tripterygium wilfordii alkaloid; 38-68 parts of triptolide; 38-58 parts of chamaejasmine; 38-58 parts of gelsemine; 86-88 parts of honeysuckle chlorogenic acid; 80-88 parts of tanshinone; 80-88 parts of curcumin; 88-98 parts of paeoniflorin; 80-88 parts of adenophora tetraphylla bunge xanthotoxin; 80-88 parts of cooked rehmannia root; 80-88 parts of oriental wormwood flavone; 80-88 parts of rose volatile oil; 88-98 parts of silybum marianum organic acid; 88-98 parts of cyperus rotundus volatile oil; 80-88 parts of prunella vulgaris alkaloid; 80-88 parts of sculellaria barbata alkaloid; 80-88 parts of selaginella doederleinii alkaloid; 80-88 parts of chrysophanol; 80-90 parts of ganoderma lucidum polysaccharide; 68-88 parts of suberect spatholobus stem element; 45-68 parts of angelica volatile oil; 68-88 parts of fructus psoraleae volatile oil. The formula is easy to obtain and uncomplicated, has no toxicity and harm to human and livestock, does not pollute the environment and crops, and has no accumulated toxic residue in human body to harm human health.

Description

Broad-spectrum plant composition for curing and radically treating liver cancer and preparation method thereof
Technical Field
The invention relates to the field of traditional Chinese medicine preparations, in particular to a broad-spectrum plant composition for curing and radically treating liver cancer and a preparation method thereof.
Background
Liver cancer belongs to the categories of diseases such as "abdominal mass", "liver mass", "fullness of qi", "distension", "jaundice" and "prostrate beam" in traditional Chinese medicine. Liver cancer refers to a malignant tumor that occurs in hepatocytes and cholangiocytes, and is common in China.
According to traditional Chinese medicine, liver cancer is mostly caused by diet internal injury, emotional disorder, damp-heat accumulation in liver and gallbladder, body qi and blood deficiency and the like or external damp invasion, so that liver and spleen are damaged, transportation and transformation are disordered, qi movement is blocked, phlegm and blood stasis are stopped internally, damp-heat and fire toxin are accumulated, and the liver cancer is gradually accumulated in the hypochondrium over a long time.
Modern medical research considers that liver cancer is mainly caused by congenital deficiency of the liver. Diseases such as viral hepatitis, liver cirrhosis, HBV infection and the like can also cause liver cancer, alcohol, aflatoxin, nitrosamines, some cholesterol-reducing western medicines, certain herbicides and some chemical substances such as 666 highly toxic pesticides and the like. Aflatoxins, a carcinogen produced by fungi that grow in peanuts, seeds, corn and other dry foods stored in humid environments, is clearly linked to liver cancer and therefore does not consume any softened, moldy, rancid, dry-wrinkled or outdated food in daily life.
Liver cancer has no obvious symptoms and signs in the early stage and is usually found by general survey or alpha-fetoprotein detection. Intermittent or continuous pain (dull pain or stabbing pain) in the liver area, epigastric fullness, anorexia, nausea, emesis, progressive hepatomegaly of the epigastric mass, emaciation, hypodynamia, fever, abdominal distension, diarrhea, jaundice, upper gastrointestinal hemorrhage, ascites, hepatic coma, rupture of hepatic nodules, hemorrhage, secondary infection, etc. The disease has high malignancy degree, fast development and short natural survival period, and is generally 2-6 months.
According to the statistical data of the global tumor epidemics, the number of newly added cancer patients is about 14 ten thousand in 2012, wherein the liver cancer patient is ranked in the sixth place of the common cancer and the number of newly added cancer patients is about 78 ten thousand every year. China is one of the countries with the highest incidence rate of liver cancer in the world, and the number of the new liver cancer patients is about 46 ten thousand every year, which is more than half of the number of the new liver cancer patients in the world.
The Chinese liver cancer is basically the middle and late stage liver cancer in hospitals, the operation capability of the middle and late stage liver cancer is stronger, the vicious circle of relapse, metastasis and death after the operation cannot be solved, and the long-term survival rate of patients can be effectively improved only by early diagnosis and early operation. For example, 60% and more than 70% of Japanese admitted patients are early-stage liver cancer, 75% or more of Chinese admitted patients are middle-and late-stage liver cancer, and the survival time of the liver cancer is poorer in China compared with that of the liver cancer in two countries. Therefore, for malignant tumors, especially liver cancer, any method can not solve the problem of high incidence of liver cancer in China without early diagnosis. The national liver cancer science center, king of the ren and hong yang, is just the same.
At present, the liver cancer pathological condition is not completely cured and radically cured by a prescription in the medical world, the main method for the comprehensive treatment of the liver cancer in China is mainly completed by surgical operation, radiotherapy and chemotherapy, and the operation, the radiotherapy and the chemotherapy can not ensure that a liver cancer patient can achieve the expected purpose of effectively curing and radically curing the pathological condition. Therefore, liver cancer patients still can not kill liver cancer cells caused by operations, radiotherapy and chemotherapy, pain and injury of toxic and side reactions of liver cancer patients such as weakness, alopecia, neurotoxin, local tissue necrosis and the like caused by negative side effects, uncertain uncontrollable factors such as diversified malignant lesions, diffusion transfer and the like, and further face death states possibly appearing in the 'and long term' at any time, and natural survival expectations of liver cancer patients cannot be met.
Disclosure of Invention
The invention aims to provide a broad-spectrum plant composition for curing and radically treating liver cancer and a preparation method thereof, and aims to solve the problems that a radical treatment prescription for liver cancer does not exist, the side effects of medicines are more, the cure rate is low, the effect taking speed is slow, and the like.
In order to achieve the purpose, the invention adopts the following technical scheme: the invention provides a broad-spectrum plant composition for curing and radically treating liver cancer, which comprises the following components in parts by weight: 38-68 parts of tripterygium wilfordii alkaloid; 38-68 parts of triptolide; 38-58 parts of chamaejasmine; 38-58 parts of gelsemine; 86-88 parts of honeysuckle chlorogenic acid; 80-88 parts of tanshinone; 80-88 parts of curcumin; 88-98 parts of paeoniflorin; 80-88 parts of adenophora tetraphylla bunge xanthotoxin; 80-88 parts of cooked rehmannia root; 80-88 parts of oriental wormwood flavone; 80-88 parts of rose volatile oil; 88-98 parts of silybum marianum organic acid; 88-98 parts of cyperus rotundus volatile oil; 80-88 parts of prunella vulgaris alkaloid; 80-88 parts of sculellaria barbata alkaloid; 80-88 parts of selaginella doederleinii alkaloid; 80-88 parts of chrysophanol; 80-90 parts of ganoderma lucidum polysaccharide; 68-88 parts of suberect spatholobus stem element; 45-68 parts of angelica volatile oil; 68-88 parts of fructus psoraleae volatile oil; 78-88 parts of astragalus saponin; 80-88 parts of elecampane inula root; 68-80 parts of aristolochin; 68-88 parts of areca peel alkaloid; 78-88 parts of achyranthes bidentata sterol; 80-88 parts of bighead atractylodes rhizome volatile oil; 80-90 parts of ophiopogon root glucose; 80-90 parts of yam germanium; 86-90 parts of semen cassiae emodin; 86-90 parts of tangerine peel flavone; 80-90 parts of lycium barbarum betaine; 80-88 parts of spora lygodii chlorogenic acid; 88-98 parts of notoginsenoside; 88-98 parts of costunolide; 80-90 parts of katsumade galangal seed volatile oil; 60-80 parts of cistanche minerals; 88-98 parts of toosendanin; 68-80 parts of morning glory seed glycosides; 80-88 parts of carthamin; 80-90 parts of paniculate swallowwort root propiophenone; 68-88 parts of long pepper volatile oil; 80-88 parts of fumaric acid; 80-88 parts of pachyman; 50-70 parts of pinellia ternate millet alcohol; 50-60 parts of lotus plumule alkaloid; 60-80 parts of broom cypress fruit alkaloid; 80-88 parts of omphalin; 78-88 parts of phytolaccagenin; 80-88 parts of folium artemisiae argyi essential oil cineole; 88-98 parts of polygonatum quinones; 80-88 parts of hawthorn flavone; 48-58 parts of sanshoamides; 80-88 parts of pueraria isoflavone; 60-80 parts of grape polymerized phenol; 85-98 parts of various trace elements of polygonum multiflorum; 150 portions of red date cyclic adenosine monophosphate and 250 portions of adenosine monophosphate; 0.4-0.8 part of folic acid; 68-88 parts of sophora flavescens alkaloids; 2-10 parts of copper sulfate; 10-16 parts of zinc sulfate; 5-10 parts of manganese sulfate; 0.01-0.08 part of penicillin sodium.
Further, the Tripterygium wilfordii alkaloid is the extract of dried root, stem, leaf of Tripterygium wilfordii hook F.H.Chen of Celastraceae; the Tripterygium wilfordii alkaloid comprises fixed alkali, increasernt, jin alkali, chun alkali and tositude, wherein the ratio of the fixed alkali to the increasernt to the jin alkali to the chun alkali to the tositude is 1:1:1:1: 1.
Further, the gelsemium elegans alkali is extract of perennial green vine of the genus calamus of the family marchaniaceae, and contains highly toxic components of the gelsemium elegans alkali.
Further, the gelsemine is extracted by organic solvent or water boiling method to obtain liquid or paste or powder with Baume degree of 15-17.
Further, the chlorogenic acid of honeysuckle is an extract of flower buds or flowers carried out of perennial enwinding lonicera jacobsoni of the family of the shrubby-loniceraceae, and contains chlorogenic acid; is liquid or slurry or powder with Baume degree of 15-17 extracted by organic solvent or water boiling method.
Further, the rose volatile oil is an extract of dried flower buds of roses of the Rosaceae family, and is composed of three components of volatile oil nerol, citronellol and phenethyl alcohol.
Further, the ganoderan is an extract of dried fruiting body of Ganoderma lucidum or Ganoderma sinense belonging to the family Polyporaceae, and comprises ganoderan, L-mannitol, and limonene.
Further, the composition comprises the following components in parts by weight: 40 parts of tripterygium wilfordii alkaloid; 55 parts of triptolide; 40 parts of chamaejasmine; 45 parts of gelsemine; 86 parts of honeysuckle chlorogenic acid; 82 parts of tanshinone; 82 parts of curcumin; 90 parts of paeoniflorin; 82 parts of adenophora tetraphylla bunge xanthotoxin; 82 parts of cooked rehmannia root; 82 parts of oriental wormwood flavone; 86 parts of rose volatile oil; 90 parts of silybum marianum organic acid; 90 parts of cyperus rotundus volatile oil; 82 parts of prunella vulgaris alkaloid; 82 parts of sculellaria barbata alkaloid; 82 parts of selaginella doederleinii hieron alkaloid; 82 parts of chrysophanol; 88 parts of ganoderma lucidum polysaccharide; 70 parts of suberect spatholobus stem element; 50 parts of angelica volatile oil; 70 parts of fructus psoraleae volatile oil; 80 parts of astragalus saponin; 82 parts of elecampane inula root; 75 parts of aristolochia debilis alkali; 70 parts of areca peel alkaloid; 80 parts of achyranthes bidentata sterol; 82 parts of bighead atractylodes rhizome volatile oil; 82 parts of radix ophiopogonis glucose; 82 parts of yam germanium; 88 parts of semen cassiae emodin; 88 parts of dried orange peel flavone; 82 parts of lycium barbarum betaine; 82 parts of spora lygodii chlorogenic acid; 90 parts of notoginsenoside; 90 parts of costunolide; 82 parts of katsumade galangal seed volatile oil; 62 parts of cistanche minerals; 90 parts of toosendanin; 70 parts of morning glory seed glycosides; 82 parts of carthamin; 82 parts of paniculate swallowwort root propiophenone; 70 parts of long pepper volatile oil; 82 parts of fumaric acid; 82 parts of pachyman; 55 parts of pinellia ternate millet alcohol; 55 parts of lotus seed core alkaloid; 70 parts of broom cypress fruit alkaloid; 82 parts of omphalin; 80 parts of phytolaccagenin; 88 parts of argy wormwood leaf essential oil cineole; 90 parts of polygonatum quinones; 82 parts of hawthorn flavone; 50 parts of sanshoamides; 82 parts of pueraria isoflavone; 62 parts of grape polymerized phenol; 86 parts of various trace elements of polygonum multiflorum; 160 parts of red date cyclic adenosine monophosphate; 0.5 part of folic acid; 70 parts of sophora flavescens alkaloids; 4 parts of copper sulfate; 13 parts of zinc sulfate; 6 parts of manganese sulfate; penicillin sodium 0.02 portion.
The invention also provides a preparation method of the broad-spectrum plant composition for curing and radically treating liver cancer,
step one, weighing medicinal materials: tripterygium wilfordii alkaloid, triptolide, chamaejasmine, gelsemium elegans, honeysuckle chlorogenic acid, tanshinone, curcumin, radix paeoniae alba paeoniflorin, adenophoral pricklyash peel toxin, cooked rehmannin, oriental wormwood flavone, rose volatile oil, silybum marianum organic acid, cyperus rotundus volatile oil, selfheal alkaloid, barbed skullcap herb alkaloid, selaginella tamariscina alkaloid, chrysophanol, ganoderan, suberect spatholobus stem element, Chinese angelica volatile oil, malaytea scurfpea fruit volatile oil, astragaloside, elecampane, aristolochia cochinchinensis, areca peel alkaloid, achyranthes bidentata sterol, bighead atractylodes rhizome volatile oil, ophiopogon glucose, yam germanium, cassia seed emodin, dried orange peel flavone, medlar betaine, climbing fern chloranthus glaber, notoginsenoside, costunolide, katsumadai galangal volatile oil, cistanche mineral matter, toosendan, morning glory glycoside, carthamin, pachyman, pinellia tuber millet alcohol, lotus plumule alkaloid, broom cypress fruit alkaloid, omphalin, phytolaccagenin, folium artemisiae argyi essential oil cineole, polygonatum quinones, hawthorn flavone, xanthoxylin, pueraria isoflavone, grape polymerized phenol, a plurality of microelements of polygonum multiflorum, red date cyclic phosphorus garlic adenosine, folic acid, sophora flavescens alkaloid, copper sulfate, zinc sulfate, manganese sulfate and penicillin sodium;
and step two, dissolving the medicines in water, and uniformly mixing.
The invention has the beneficial effects that:
the broad-spectrum plant composition for curing and radically curing liver cancer and the preparation method thereof provided by the invention refresh the principle of curing and radically curing cancer therapy, scientifically break through the bound bottleneck of the traditional Chinese medicine treatment theory and practice in clinical application, and open the subversive precedent that new Chinese medicine field of new era has the capability of curing and radically curing various cancers with high efficiency. The 'refreshment therapy' revolutionized the effect of cancer treatment and more revolutionized the concept of cancer treatment.
The broad-spectrum plant composition for curing and radically treating liver cancer and the preparation method thereof have the advantages of easily obtained and uncomplicated formula, no toxicity and harm to human and livestock, no environmental pollution and crop pollution, and no toxic residue accumulated in human body and harm to human health.
3, the prevention and treatment effect is good, the production cost is controllable, the technical problem of curing and radically treating liver cancer in clinical application can be achieved, and the medicine can enable a liver cancer patient to avoid the pain and the injury of toxic and side reactions such as weakness, alopecia, neurotoxicity, local tissue necrosis and the like of the liver cancer patient caused by killing liver cancer cells due to factor treatment such as operation, radiotherapy, chemotherapy, targeted therapy, immunotherapy and the like. Has high popularization value.
4, the medicine can be used for treating liver cancer patients on the basis of treatment of the liver cancer patients with or without factors such as operation, radiotherapy, chemotherapy, targeted therapy, immunotherapy and the like, the liver cancer patients only need to continuously and conveniently drink 4-6 ml to 6-8 months of the broad-spectrum plant composition liquid matter for curing and radically treating liver cancer in a cold oral mode every day, liver cancer can be effectively cured and radically treated, relapse cannot occur within 5 years, natural survival becomes possible, the effective rate is 1%, and the cure rate is 98.88-1%.
Additional features and advantages of the invention will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by the practice of the invention. The primary objects and other advantages of the invention may be realized and attained by the instrumentalities particularly pointed out in the specification.
Detailed Description
The technical solutions of the present invention are described in detail below by examples, and the following examples are only exemplary and can be used only for explaining and illustrating the technical solutions of the present invention, but not construed as limiting the technical solutions of the present invention.
The invention provides a broad-spectrum plant composition for curing and radically treating liver cancer, which comprises the following components in parts by weight: 38-68 parts of tripterygium wilfordii alkaloid; 38-68 parts of triptolide; 38-58 parts of chamaejasmine; 38-58 parts of gelsemine; 86-88 parts of honeysuckle chlorogenic acid; 80-88 parts of tanshinone; 80-88 parts of curcumin; 88-98 parts of paeoniflorin; 80-88 parts of adenophora tetraphylla bunge xanthotoxin; 80-88 parts of cooked rehmannia root; 80-88 parts of oriental wormwood flavone; 80-88 parts of rose volatile oil; 88-98 parts of silybum marianum organic acid; 88-98 parts of cyperus rotundus volatile oil; 80-88 parts of prunella vulgaris alkaloid; 80-88 parts of sculellaria barbata alkaloid; 80-88 parts of selaginella doederleinii alkaloid; 80-88 parts of chrysophanol; 80-90 parts of ganoderma lucidum polysaccharide; 68-88 parts of suberect spatholobus stem element; 45-68 parts of angelica volatile oil; 68-88 parts of fructus psoraleae volatile oil; 78-88 parts of astragalus saponin; 80-88 parts of elecampane inula root; 68-80 parts of aristolochin; 68-88 parts of areca peel alkaloid; 78-88 parts of achyranthes bidentata sterol; 80-88 parts of bighead atractylodes rhizome volatile oil; 80-90 parts of ophiopogon root glucose; 80-90 parts of yam germanium; 86-90 parts of semen cassiae emodin; 86-90 parts of tangerine peel flavone; 80-90 parts of lycium barbarum betaine; 80-88 parts of spora lygodii chlorogenic acid; 88-98 parts of notoginsenoside; 88-98 parts of costunolide; 80-90 parts of katsumade galangal seed volatile oil; 60-80 parts of cistanche minerals; 88-98 parts of toosendanin; 68-80 parts of morning glory seed glycosides; 80-88 parts of carthamin; 80-90 parts of paniculate swallowwort root propiophenone; 68-88 parts of long pepper volatile oil; 80-88 parts of fumaric acid; 80-88 parts of pachyman; 50-70 parts of pinellia ternate millet alcohol; 50-60 parts of lotus plumule alkaloid; 60-80 parts of broom cypress fruit alkaloid; 80-88 parts of omphalin; 78-88 parts of phytolaccagenin; 80-88 parts of folium artemisiae argyi essential oil cineole; 88-98 parts of polygonatum quinones; 80-88 parts of hawthorn flavone; 48-58 parts of sanshoamides; 80-88 parts of pueraria isoflavone; 60-80 parts of grape polymerized phenol; 85-98 parts of various trace elements of polygonum multiflorum; 150 portions of red date cyclic adenosine monophosphate and 250 portions of adenosine monophosphate; 0.4-0.8 part of folic acid; 68-88 parts of sophora flavescens alkaloids; 2-10 parts of copper sulfate; 10-16 parts of zinc sulfate; 5-10 parts of manganese sulfate; 0.01-0.08 part of penicillin sodium.
Further, the Tripterygium wilfordii alkaloid is the extract of dried root, stem, leaf of Tripterygium wilfordii hook F.H.Chen of Celastraceae; the Tripterygium wilfordii alkaloid comprises fixed alkali, increasernt, jin alkali, chun alkali and tositude, wherein the ratio of the fixed alkali to the increasernt to the jin alkali to the chun alkali to the tositude is 1:1:1:1: 1.
Wherein the gelsemium elegans alkali is extract of perennial green vine of Callicarpa of Loganiaceae, and contains highly toxic components of gelsemium elegans alkali. The gelsemine is extracted by organic solvent or water decoction method and has Baume degree of 15-17, and is in the form of liquid, paste or powder. The chlorogenic acid of honeysuckle is extract of flower buds or flowers which come out of the flower buds of a perennial winding shrubby-Caprifoliaceae plant, and contains chlorogenic acid; is liquid or slurry or powder with Baume degree of 15-17 extracted by organic solvent or water boiling method. The rose volatile oil is extract of dried flower bud of rose belonging to Rosaceae, and comprises volatile oils such as nerol, citronellol and phenethyl alcohol. The ganoderan is extract of dried fruiting body of Ganoderma lucidum karst or Ganoderma sinense Zhang of Polyporaceae, and comprises ganoderan, L-mannitol and olefin.
The composition comprises the following components in parts by weight: 40 parts of tripterygium wilfordii alkaloid; 55 parts of triptolide; 40 parts of chamaejasmine; 45 parts of gelsemine; 86 parts of honeysuckle chlorogenic acid; 82 parts of tanshinone; 82 parts of curcumin; 90 parts of paeoniflorin; 82 parts of adenophora tetraphylla bunge xanthotoxin; 82 parts of cooked rehmannia root; 82 parts of oriental wormwood flavone; 86 parts of rose volatile oil; 90 parts of silybum marianum organic acid; 90 parts of cyperus rotundus volatile oil; 82 parts of prunella vulgaris alkaloid; 82 parts of sculellaria barbata alkaloid; 82 parts of selaginella doederleinii hieron alkaloid; 82 parts of chrysophanol; 88 parts of ganoderma lucidum polysaccharide; 70 parts of suberect spatholobus stem element; 50 parts of angelica volatile oil; 70 parts of fructus psoraleae volatile oil; 80 parts of astragalus saponin; 82 parts of elecampane inula root; 75 parts of aristolochia debilis alkali; 70 parts of areca peel alkaloid; 80 parts of achyranthes bidentata sterol; 82 parts of bighead atractylodes rhizome volatile oil; 82 parts of radix ophiopogonis glucose; 82 parts of yam germanium; 88 parts of semen cassiae emodin; 88 parts of dried orange peel flavone; 82 parts of lycium barbarum betaine; 82 parts of spora lygodii chlorogenic acid; 90 parts of notoginsenoside; 90 parts of costunolide; 82 parts of katsumade galangal seed volatile oil; 62 parts of cistanche minerals; 90 parts of toosendanin; 70 parts of morning glory seed glycosides; 82 parts of carthamin; 82 parts of paniculate swallowwort root propiophenone; 70 parts of long pepper volatile oil; 82 parts of fumaric acid; 82 parts of pachyman; 55 parts of pinellia ternate millet alcohol; 55 parts of lotus seed core alkaloid; 70 parts of broom cypress fruit alkaloid; 82 parts of omphalin; 80 parts of phytolaccagenin; 88 parts of argy wormwood leaf essential oil cineole; 90 parts of polygonatum quinones; 82 parts of hawthorn flavone; 50 parts of sanshoamides; 82 parts of pueraria isoflavone; 62 parts of grape polymerized phenol; 86 parts of various trace elements of polygonum multiflorum; 160 parts of red date cyclic adenosine monophosphate; 0.5 part of folic acid; 70 parts of sophora flavescens alkaloids; 4 parts of copper sulfate; 13 parts of zinc sulfate; 6 parts of manganese sulfate; penicillin sodium 0.02 portion.
The preparation method of the broad-spectrum plant composition for curing and radically treating liver cancer,
step one, weighing medicinal materials: tripterygium wilfordii alkaloid, triptolide, chamaejasmine, gelsemium elegans, honeysuckle chlorogenic acid, tanshinone, curcumin, radix paeoniae alba paeoniflorin, adenophoral pricklyash peel toxin, cooked rehmannin, oriental wormwood flavone, rose volatile oil, silybum marianum organic acid, cyperus rotundus volatile oil, selfheal alkaloid, barbed skullcap herb alkaloid, selaginella tamariscina alkaloid, chrysophanol, ganoderan, suberect spatholobus stem element, Chinese angelica volatile oil, malaytea scurfpea fruit volatile oil, astragaloside, elecampane, aristolochia cochinchinensis, areca peel alkaloid, achyranthes bidentata sterol, bighead atractylodes rhizome volatile oil, ophiopogon glucose, yam germanium, cassia seed emodin, dried orange peel flavone, medlar betaine, climbing fern chloranthus glaber, notoginsenoside, costunolide, katsumadai galangal volatile oil, cistanche mineral matter, toosendan, morning glory glycoside, carthamin, pachyman, pinellia tuber millet alcohol, lotus plumule alkaloid, broom cypress fruit alkaloid, omphalin, phytolaccagenin, folium artemisiae argyi essential oil cineole, polygonatum quinones, hawthorn flavone, xanthoxylin, pueraria isoflavone, grape polymerized phenol, a plurality of microelements of polygonum multiflorum, red date cyclic phosphorus garlic adenosine, folic acid, sophora flavescens alkaloid, copper sulfate, zinc sulfate, manganese sulfate and penicillin sodium;
and step two, dissolving the medicines in water, and uniformly mixing.
Example 1
The composition comprises the following components in parts by weight: the tripterygium wilfordii alkaloid is an extract of dry roots, stems and leaves of tripterygium wilfordii of Celastraceae and consists of five types of alkaloid, increasertibine, wilfordine, chunaine and threepine, and the tripterygium wilfordii alkaloid has the characteristics of broad spectrum, high efficiency, various action modes and the like on cancer cells, and has the advantages of unique action mechanism, complex action parts, good prevention and treatment effect in clinical application, high cure rate, and different treatment of the same diseases and the same diseases. The chemical component of the tripterygium wilfordii alkaloid, namely sesquiterpene alkaloid, is a main physiological active substance in tripterygium wilfordii, the action mechanism of the tripterygium wilfordii alkaloid on various types of cancer cells causes slow action, stopping taking food, then anaesthetizing, and then reviving or dying of toxic cancer cells of a test mouse and a human body, and the revived cancer cells can be taken food, anaesthetized, revived or killed again. Tripterygium wilfordii contains more than 20 kinds of alkaloid, and the alkali fixing, alkali increasing, alkali promoting, alkali relieving and alkali throwing adopted by the invention has better activity of 'twitching and killing' various types of cancer cells than other alkaloids.
38-68 parts of triptolide, wherein the triptolide is an extract of dried root of tripterygium wilfordii belonging to Celastraceae, contains triptolide, is a diterpene lactone with various biological activities, is derived from the root of tripterygium wilfordii belonging to medicinal plants, has the effect of 'killing' various types of cancer cells, and can be used together with tripterygium wilfordii alkaloid to enhance the effect of 'killing' various types of cancer cells.
38-58 parts of stellera chamaejasme, wherein the stellera chamaejasme is an extract of stellera chamaejasme plants, and also contains diterpene and volatile oil substance components, is a liquid substance, a paste substance or a powder substance with the Baume degree of 15-17, which is extracted from one or two of roots, stems or leaves or three of the stellera chamaejasme by using an organic solvent or a boiling method, and the stellera chamaejasme is new chamaejasme A, new chamaejasme B or chamaejasmine dry powder extracted from the stellera chamaejasme, contains diterpene and volatile oil substance components, and has the effects of broad-spectrum anticancer, sterilization and insecticidal action.
38-58 parts of gelsemine, wherein the gelsemine is an extract of perennial green vine of the genus calamus of the family marchaniaceae, contains a highly toxic component of the gelsemine, is a liquid or paste or powder with a baume degree of 15-17 extracted by an organic solvent or a water boiling method, and has the effects of dispelling wind, counteracting toxic substances, reducing swelling, relieving pain, resisting liver cancer and the like.
86-88 parts of honeysuckle chlorogenic acid, wherein the honeysuckle chlorogenic acid is an extract of a flower bud or a flower carried out of a perennial entangled jaboticaceae plant, contains chlorogenic acid components, is a liquid or paste or powder with the Baume degree of 15-17 extracted by an organic solvent or a water boiling method, and has the effects of resisting liver cancer, inhibiting the mutagen of carcinogens of aflatoxin and benzopyrene by inhibiting activating enzyme, and preventing liver cancer by reducing the utilization rate of the carcinogens and the transportation of the carcinogens in the liver.
80-88 parts of tanshinone, wherein the tanshinone is root extract of a perennial herb salvia miltiorrhiza bunge of Labiatae, contains two components of tanshinone and tanshinone, and has the effects of promoting tissue repair and regeneration and inhibiting the growth of hyperproliferation fibroblasts and tumors.
80-88 parts of curcumin, wherein the curcumin is dry root tuber of perennial herb curcuma longa of Zingiberaceae, and extract of dry rhizome of the curcuma longa contains pigment component curcumin, and has the effects of resolving stagnation, promoting qi circulation, removing blood stasis, relieving pain, reducing phlegm, cooling blood, clearing blood, promoting bile flow, removing jaundice, promoting bile secretion, enhancing liver function and protecting and nourishing liver.
88-98 parts of paeoniflorin, which is an extract of root of a perennial herbaceous plant peony of Ranunculaceae, contains paeoniflorin components, and has effects of promoting lymphoblast transformation and inhibiting tumor growth. Has certain promotion effect on cellular immunity and humoral immunity.
80-88 parts of adenophoral xanthotoxin, which is root extract of adenophora tetraphylla and adenophora tetraphylla of Campanulaceae, contains xanthotoxin component, has inhibitory effect on ascites carcinoma and sarcoma, and can convert charges on the surface membrane of hepatocarcinoma cell to normal direction.
80-88 parts of cooked rehmannia root, which contains catalpol and amino acid, is prepared by processing rehmannia root which is a perennial herb of Scrophulariaceae family, has the function of promoting the transformation of liver cancer cells and increasing the number of white blood cells and platelets, thereby improving the immune function of the organism and being beneficial to inhibiting the growth of tumors.
80-88 parts of oriental wormwood flavone, wherein the oriental wormwood flavone is an extract of dried aerial parts of artemisia scoparia or artemisia capillaries belonging to the family of Compositae, contains oriental wormwood flavone components, and has the effects of reducing jaundice, clearing damp-heat and the like.
80-88 parts of rose volatile oil which is an extract of dried flower buds of roses of Rosaceae and consists of three components of volatile oil nerol, citronellol and phenethyl alcohol, and has the effects of activating blood, promoting qi circulation, relieving depression, relieving pain, resisting viruses, promoting bile secretion, resisting liver cancer and the like.
88-98 parts of organic acid of silybum marianum, wherein the organic acid of silybum marianum is an extract of dry mature fruit of silybum marianum of Compositae, and comprises five organic acids of linolenic acid, glutamic acid, quercetin, sterol stigmasterol and other silymarin, and has the effects of soothing liver and benefiting gallbladder, clearing heat and detoxicating, reducing blood fat, resisting liver injury, resisting atheroma, reducing blood sugar, inhibiting platelet aggregation, resisting cerebral ischemia, resisting tumor and the like.
88-98 parts of cyperus rotundus volatile oil, wherein the cyperus rotundus volatile oil is a dry stem extract of cyperus rotundus of cyperus, is composed of volatile oils of camphene, b-pinene and cyperus rotundus alkene, has the effects of regulating menstruation, relieving pain, promoting qi circulation, relieving depression, promoting bile secretion, inhibiting intestinal smooth muscle, relaxing uterine smooth muscle, and has estrogen-like effects, hypnosis, antipyresis, heart strengthening, pathogenic microorganism resisting, inflammation resisting and the like.
80-88 parts of prunella vulgaris alkaloid which is an extract of cluster or whole plant of perennial plant prunella vulgaris of the family labiatae, contains alkaloid components and has the effect of inhibiting the growth of liver cancer cells.
80-88 parts of sculellaria barbata alkaloid which is an extract of aerial parts or whole grass of perennial herb of stenotrophospermum angustifolia of Labiatae, contains alkaloid and has obvious effect of inhibiting the growth of liver cancer cells.
80-88 parts of selaginella doederleinii alkaloid which is an extract of the whole plant of selaginella doederleinii of Selaginellaceae, contains alkaloid components, has the effect of inhibiting the growth of hepatoma carcinoma cells, and can enhance the adrenal cortex function, the organism metabolism and the reticuloendothelial system function.
80-88 parts of chrysophanol, wherein the chrysophanol is an extract of dried roots and rhizomes of Rheum palmatum L.var.palmatum L.var.maxim.Et rhizoma Rhei, Rheum emodin, rhein, glycoside emodin glucoside, chrysophanol glucoside and other d-catechin, and has the effects of purgation, pancreatic secretion promotion, bile secretion promotion, liver injury resistance, duodenal ulcer resistance, antifungal virus resistance, inflammation resistance, hemostasis, blood fat reduction, diuresis, liver cancer resistance, blood uric acid nitrogen reduction, and liver muscle reduction.
80-90 parts of ganoderma lucidum polysaccharide, wherein the ganoderma lucidum polysaccharide is an extract of dried fruiting bodies of ganoderma lucidum or ganoderma sinensis belonging to the family Polyporaceae, is composed of ganoderma lucidum polysaccharide, L-mannitol and olefine alcohol and has the effects of tonifying liver qi, benefiting heart qi, nourishing lung qi, strengthening kidney qi, benefiting essence qi and the like. The ganoderan also has effects of accelerating accounting and protein metabolism, promoting hematopoiesis, enhancing body constitution, enhancing phagocytic ability of reticuloendothelial system, and enhancing immunity.
68-88 parts of suberect spatholobus stem element, wherein the suberect spatholobus stem element is an extract of stems of spatholobus stem leguminous, such as Panzhihua honey locust beans, Millettia dielsiana and the like, contains suberect spatholobus stem element components, has obvious effect of inhibiting liver cancer cells, and has the effect of enriching blood. And has effects in increasing blood cells and hemoglobin.
45-68 parts of angelica volatile oil which is an extract of the root of angelica sinensis which is a perennial herb of the family Umbelliferae, contains volatile oil components and has the function of inhibiting tumor cells.
68-88 parts of fructus Psoraleae volatile oil, wherein the fructus Psoraleae volatile oil is seed extract of fructus Psoraleae of annual herb of Leguminosae, contains volatile oil components, and has effect in resisting hepatocarcinoma.
78-88 parts of astragaloside, wherein the astragaloside is root extract of leguminous perennial herb astragalus and inner Mongolia astragalus, also contains two components of amino acid and trace folic acid, and has the effects of improving the immunity of liver cancer patients, strengthening heart, promoting urination, reducing blood pressure, protecting liver, expanding blood vessels, improving blood circulation and reducing proteinuria.
80-88 parts of elecampane inula root, wherein the elecampane inula root volatile oil is an extract of dried roots of elecampane inula root of the family Compositae, is composed of three types of volatile oil isoalantolactone, alantolactone and dihydroisoalantolactone, and has the effects of regulating qi, relieving depression, strengthening spleen and stomach, relieving pain, resisting bacteria, expelling parasites, preventing miscarriage and the like.
68-80 parts of aristolochin, which is an extract of dry aerial parts of aristolochia debilis or aristolochia debilis of aristolochiaceae, contains magnoflorine components, and has the effects of inducing diuresis to alleviate edema, promoting qi and blood circulation, resisting liver cancer, inhibiting bacteria, lowering blood pressure and the like.
68-88 parts of areca peel alkaloid which is an extract of dried peel of areca catechu of the palmaceae family, consists of alkaloids arecoline and arecoline II, and has the effects of promoting diuresis, relieving swelling, relieving qi stagnation, promoting fibrinolysis, enhancing gastrointestinal smooth muscle contraction force and the like.
78-88 parts of achyranthosterol, wherein the achyranthosterol is an extract of dry roots of achyranthes bidentata belonging to the family Amaranthaceae, contains two components of sterol and saponin, and has the effects of dispelling blood stasis, eliminating carbuncle and swelling, guiding blood downward, tonifying liver and kidney, strengthening muscles and bones and the like.
80-88 parts of bighead atractylodes rhizome volatile oil, wherein the bighead atractylodes rhizome volatile oil contains two components of xanthinol and xanthenone, is an extract of rhizomes of largehead atractylodes rhizome which is a perennial herb of Compositae, and has the effect of inhibiting liver cancer. The tumor inhibiting mechanism is related to the reduction of the proliferation rate of cancer cells, the reduction of the invasiveness of tumor tissues, the improvement of the anti-tumor reaction capability of organisms and the cytotoxic effect on tumor cells. The volatile oil component of Atractylodis rhizoma also has obvious and lasting diuretic effect. Has effects in reducing blood sugar, strengthening body constitution, resisting blood coagulation, and inhibiting bacteria. Secondly, the medicine has an increasing effect on the leucocyte reduction caused by chemotherapy or radiotherapy.
80-90 parts of ophiopogon glucose, wherein the ophiopogon glucose is a small root extract on fibrous roots of Ophiopogon japonicus or Ophiopogon japonicus of Liliaceae, consists of multiple steroidal saponins, amino acids and glucose, and has the effects of increasing the number of peripheral leukocytes, enhancing the immunologic function of human body, improving the adaptability of organism, increasing the phagocytic function of reticuloendothelial system and inhibiting the growth of liver cancer cells. And has effects of promoting recovery of islet cell function, increasing hepatic glycogen, and reducing blood glucose.
80-90 parts of yam germanium, wherein the yam germanium is a tuberous root extract of yam which is a perennial sprawling herbaceous plant of dioscoreaceae, contains a germanium component, and the germanium component can inhibit liver cancer cell transfer and improve the phagocytic capacity of liver cancer cells. Can be used together with other anticancer components to make the preparation have rapid and synergistic effect.
86-90 parts of semen cassiae emodin, wherein the semen cassiae emodin is a dried mature seed extract of an annual herb semen cassiae in leguminosae, also contains an emodin glucoside component, and has the effects of clearing liver and improving vision, relaxing bowel, resisting liver cancer and the like.
86-90 parts of tangerine peel flavone, wherein the tangerine peel flavone is a dried mature pericarp extract of citrus reticulata blanco of Rutaceae, consists of two flavonoids of neohesperidin and hesperidin, and has the effects of drying and rendering to reduce phlegm, regulating qi-flowing and strengthening spleen, resisting gastric ulcer, promoting digestive juice secretion, resisting liver injury, resisting liver cancer and the like.
80-90 parts of lycium barbarum betaine, wherein the lycium barbarum betaine is an extract of fruits of lycium barbarum of solanaceae, contains betaine components, and has the effects of tonifying deficiency, soothing nerves, improving eyesight, dispelling wind, nourishing kidney, moistening lung, protecting liver, resisting tumors and the like.
80-88 parts of lygodium japonicum chlorogenic acid which is a dried mature spore extract of lygodium japonicum of family lygodium and contains organic acid chlorogenic acid, and has the effects of treating stranguria, relieving pain, clearing damp and heat and the like.
88-98 parts of notoginsenoside which is an extract of the root of panax notoginseng of Araliaceae, contains notoginsenoside components, can bidirectionally regulate blood sugar, and has more remarkable effect of dissolving sugar when being matched with yam rich in mucin. In addition, the pseudo-ginseng decoction component can also enhance the blood vessel elasticity and effectively prevent and treat hypertension.
88-98 parts of costunolide, wherein the costunolide is extract of dried root of costus root of Compositae, and is prepared from lactone, costunolide, sterol: stigmasterol, volatile oils: costunolide, organic acids: palmitic acid, other species: the costustoot is composed of five kinds of costustoot, and has the effects of strengthening spleen to promote digestion, promoting qi circulation to relieve pain, promoting secretion of digestive juice, promoting gastrointestinal motility, relaxing tracheal smooth muscle, benefiting gallbladder, inhibiting bacteria and the like.
80-90 parts of katsumadai seed volatile oil, wherein the katsumadai seed volatile oil contains eucalyptol, linalool, camphor and acetyl borneol ester, is a dried nearly mature seed extract of katsumadai seed of Zingiberaceae, and has the effects of warming stomach, relieving vomit, eliminating dampness, strengthening spleen, resisting liver cancer, increasing pepsin activity and the like.
60-80 parts of cistanche deserticola mineral, wherein the cistanche deserticola mineral is the extract of fleshy stems with scaly leaves of cistanche deserticola of the Orobanchaceae, contains mineral components, and has the effects of tonifying kidney qi, benefiting essence and blood, moistening intestine dryness, relaxing bowels, resisting liver cancer and the like.
88-98 parts of toosendanin, wherein the toosendanin is the dried mature fruit extract of toosendan fruit of Meliaceae, contains toosendanin component, and has the effects of soothing liver, promoting qi circulation, relieving pain, expelling parasites, inhibiting bacteria, and the like.
68-80 parts of morning glory seed glycoside, wherein the morning glory seed glycoside is the extract of dry mature seeds of petunia hybrida or petunia schneideriana of Convolvulaceae, contains morning glory seed glycoside components, and has effects of purging water, relaxing bowels, eliminating phlegm, removing pathogenic accumulation, killing parasites, relieving asthma and cough, relieving abdominal pain due to parasitic accumulation, promoting enterokinesia, and exciting uterus.
80-88 parts of carthamin, wherein the carthamin is a dry extract of Carthamus tinctorius L of Compositae, contains carthamin components, and has effects of promoting blood circulation, dredging collaterals, removing blood stasis, relieving pain, and resisting liver cancer.
80-90 parts of paniculate swallowwort root propiophenone, wherein the paniculate swallowwort root propiophenone comprises four kinds of isopaeonol, paeonol glycoside and paeoniflorin, is an extract of dry roots and rhizomes of paniculate swallowwort root of Asclepiadaceae, and has the effects of relieving pain, dispelling wind and removing dampness, relieving itching, tranquilizing, relieving fever, lowering blood pressure, resisting inflammation, increasing coronary blood flow, resisting arrhythmia, reducing blood fat, resisting atherosclerosis, resisting thrombosis, inhibiting platelet aggregation, resisting bacteria and the like.
68-88 parts of long pepper volatile oil, wherein the long pepper volatile oil is a dry mature fruit ear extract of long pepper of Piperaceae, contains volatile oil components, and has the effects of warming middle-jiao to dispel cold, promoting qi circulation to relieve pain, tonifying five-strain seven-wound, resisting liver cancer and the like.
80-88 parts of fumaric acid, wherein the fumaric acid is tuber extract of corydalis tuber of corydalis family, contains fumaric acid component, and has effects of promoting blood circulation, removing blood stasis, promoting qi circulation and relieving pain.
80-88 parts of pachymaran which is an extract of dried sclerotium of Poria cocos (a fungus belonging to family Polyporaceae), contains pachymaran component, and has effects of resisting liver injury, promoting urination, resisting gastric ulcer, resisting tumor, and enhancing immunity of diabetic patients. In addition, pachyman can obviously increase the phagocytic function of macrophages and enhance the function of T lymphocytes, and has good anti-tumor effect. Especially has effects in improving myocardial contraction, inhibiting gastric ulcer, protecting liver, preventing hepatocyte necrosis, promoting diuresis, and lowering blood sugar.
50-70 parts of pinellia tuber sitosterol, wherein the pinellia tuber sitosterol is an extract of tuber of pinellia tuber of Araceae, contains the sitosterol component, and has the effects of eliminating dampness and phlegm, lowering adverse qi and preventing vomiting, relieving distension and fullness and dissipating mass and the like.
50-60 parts of lotus plumule alkaloid which is an extract of dry mature seeds of lotus of Nymphaeaceae, contains three components of alkaloid, liensinine and protein, and has the effects of strengthening spleen, relieving diarrhea, tonifying kidney, securing essence, nourishing heart, tranquilizing mind, thickening intestines and stomach, strengthening bones and muscles, tonifying deficiency, benefiting ears and eyes, removing cold and dampness, quenching thirst, removing heat, benefiting strength, treating various leukorrhagia and metrorrhagia diseases of women, promoting heart qi circulation, removing various diseases and the like.
60-80 parts of fructus kochiae alkaloid which is an extract of dried mature fruit of fructus kochiae of the family of the vine, contains alkaloid Harbin component, has the effects of mainly treating bladder heat, promoting urination, tonifying middle-jiao and vital essence, making people hearing and vision clear, lightening the body, preventing aging, and removing heat from skin to make human muscle
Figure BDA0002663000560000141
Moistening, dispersing malignant boil and abdominal mass, nourishing yin, treating diseases of yin and egg, dispelling pathogenic wind, relieving itching, clearing heat, promoting diuresis, inhibiting bacteria, inhibiting delayed hypersensitivity, and regulating phagocytic function of mononuclear macrophage.
80-88 parts of omphalin, wherein the omphalin is a dried sclerotium extract of omphalia of white mushroom family, contains protease omphalin components, and has the effects of killing insects, removing food retention, expelling and killing trichomonas, tapeworm, hookworm, ascaris, resisting liver cancer, enhancing the immune function of organisms and the like.
78-88 parts of phytolaccagenin, which is an extract of dry root of phytolacca acinosa or phytolacca acinosa of phytolaccaceae, contains phytolaccagenin components, and has the effects of expelling water and reducing swelling, detoxifying and eliminating stagnation, promoting urination and defecation, resisting inflammation, diuresis, virus and bacteria, enhancing immunity, inhibiting stress ulcer, resisting liver cancer and the like.
80-88 parts of folium artemisiae argyi essential oil cineole which is a dry extract of folium artemisiae argyi of a Compositae plant and contains essential oil cineole, and has the effects of warming channels to stop bleeding, dispelling cold to stop pain, improving blood circulation, warming the body, preventing anemia, detoxifying, purifying blood, improving allergic constitution, treating dysmenorrhea and the like.
88-98 parts of polygonatquinones, wherein the polygonatquinones are rhizome extracts of polygonatum cyrtonema of liliaceae, consist of quinones and cardiac glycoside, and have the effects of strengthening spleen, moistening lung, nourishing yin, promoting fluid production, strengthening middle-jiao, replenishing qi, nourishing, strengthening muscles and bones, reducing blood sugar, reducing blood pressure and the like. In addition, it can prevent atherosclerosis and fatty infiltration of liver, promote the formation of immunoglobulin, and improve disease resistance of human body.
80-88 parts of hawthorn flavone which is an extract of dry mature fruits of Crataegus pinnatifida and Crataegus pinnatifida of Rosaceae, contains hawthorn flavone components, can block and reduce the generation of free radicals, can enhance the immunity of the organism, and has the effects of resisting aging and resisting tumors.
48-58 parts of sanshoamides, wherein the sanshoamides contain sanshoamides and sanshoamides, are fruit peel extracts of zanthoxylum bungeanum belonging to Rutaceae, are liquid substances, pulp substances or powder substances with the Baume degree of 15-17 extracted by an organic solvent or a water boiling method, and have the effects of warming middle-jiao and supporting yang, dispelling cold and eliminating dampness, relieving itching, expelling parasites and the like.
80-88 parts of pueraria isoflavone which is an extract of the root of kudzu vine of a sphenoidaceae plant, contains isoflavone components, and has the effects of relieving exterior syndrome, reducing fever, reducing blood fat, blood pressure and blood sugar, promoting the production of body fluid to quench thirst, stopping diarrhea, moistening skin, recovering skin elasticity, promoting the development and enlargement of women breast, enabling women breast to be upright and the like. The isoflavone can also slow down the aging of bone tissue cells, help the absorption of calcium, reduce the loss of calcium drum, increase bone density and prevent the hollow digestion of bones, thereby keeping away from the effects of osteoporosis and the like.
60-80 parts of grape polymerized phenol, wherein the grape polymerized phenol is an extract of peel and seed of mature fruit of the vine of the deciduous vine plant, and also contains three components of purpurin, flavone and resveratrol, and the components of the purpurin and the flavone have the effects of effectively removing free radicals of a human body, preventing cells from being oxidized and preventing thrombosis. The grape seed extract flavone has the effects of reducing oxidation of bad cholesterol, preventing formation of cholesterol plaque, protecting eyes and effectively preventing vision deterioration and decline. In addition, the resveratrol component rich in the grape skin can effectively inhibit the operation of inflammatory substances, relieve allergic symptoms and prevent canceration of cells, has the effects of reducing rejection reaction of cancer patients after operation, radiotherapy and chemotherapy, can effectively block the transfer and diffusion of cancerated cancer cells, and has stronger cancer prevention, anticancer and cancer treatment effects. The polymerized phenol component has protein compound capable of automatically controlling virus and bacteria, has killing effect on gray virus of spinal cord and other viruses, and can promote body of cancer patient to produce antibody.
85-98 parts of polygonum multiflorum multiple trace elements, wherein the polygonum multiflorum multiple trace elements are dry root tuber extracts of polygonum multiflorum of the family polygonaceae, contain multiple trace element substances, and are liquid, pulp or powder with the Baume degree of 15-17 extracted by an organic solvent or a water boiling method. Fleece-flower root, one of the four immortals grass in China (fleece-flower root, rhizoma polygonati, rehmannia root and lucid ganoderma), records in Kaibao Bencao and calls black beard and hair, can nourish the color, strengthen the muscles and bones after being taken for a long time, benefit the essence and marrow and prolong the life. The compendium of materia Medica describes He shou Wu as if it is white entering qi system and red entering blood system. .. the product is bitter in taste. The Chinese herbal medicine has the effects of tonifying the kidney and warming and tonifying the liver, can nourish the blood and benefit the liver, control nocturnal emission and tonify the kidney, strengthen bones and muscles and blacken hair of temples, and is a good tonic medicine. It is not cold and dry, and is superior to Di Huang and Tian Dong. The composition is used in combination with anticancer drugs, and has the effect of enabling the whole medicament to achieve the effects of rapidness and synergism.
150-250 parts of red date cyclic adenosine monophosphate, wherein the red date cyclic adenosine monophosphate is a mature fruit extract of a jujube tree which is a plant of deciduous shrub or small tree of Rhamnaceae, contains cyclic adenosine monophosphate components, has the effects of expanding blood vessels, improving the nutritional status of cardiac muscle, improving the myocardial contractility, facilitating the normalized activity of heart, and has strong effects of nourishing, inhibiting cancer cells, and even converting cancer cells into normal cells. The composition is used in combination with other anti-cancer drug components according to the house renting principle, and has the effects of making the whole drug rapid and synergistic.
0.4-0.8 part of folic acid, which is also called vitamin M and vitamin Bc, exists in liver, kidney, yeast, beans, spinach, tomato and the like, is an indispensable nutrient in the cell manufacturing process, is also an essential factor for synthesizing protein and nucleic acid, hemoglobin, rapid generation of erythrocytes and leukocytes, metabolism of amino acid and metabolism of long-chain fatty acid in brain are all few, has the characteristics of abundant, diversified and sufficient nutrient content and the like, is an indispensable important nutrient element for keeping the normal operation of a comprehensive system in a liver cancer patient body, and has the effects of detoxification, oxidation resistance and the like. The composition can be used together with other plant source substances, so that the whole medicament in the formula principle has the effects of rapidness and synergism.
68-88 parts of radix sophorae flavescentis alkaloid which is root extract of radix sophorae flavescentis of leguminosae, contains alkaloid and has the effects of clearing heat, promoting urination, eliminating dampness, killing insects and the like.
2-10 parts of copper sulfate and the copper sulfate, which can be used for maintaining the health of the central nervous system of a human body while participating in normal hematopoiesis of the human body. Because insulin secretion in humans is regulated by central nervous influences, copper sulfate plays a role in the treatment of cancer. Although copper sulfate belongs to heavy metal, it is one of indispensable trace elements required by human body for a long time, and researches of scientists prove that copper ions do not have accumulated toxicity to harm human health, and normal people need to take the copper ions every day and can obtain the copper ions from food generally. The composition is used in combination with other plant-derived anti-liver cancer substances according to the formula principle, so that the whole medicament has strong, rapid and synergistic effects.
10-16 parts of zinc sulfate, which is an important component of insulin in a human body, has the effect of influencing various functions of an endocrine system of the human body, and can be combined with the insulin to form a compound to form a new system, so that the zinc sulfate can automatically generate, store and release the insulin to regulate blood sugar according to the change of the blood sugar level of the human body. Once a human body lacks zinc sulfate, the immune function is reduced, and various infectious diseases are easy to occur, so that liver cancer is caused. The composition is used in combination with other plant-derived anti-liver cancer substances according to the formula principle, so that the whole medicament has strong, rapid and synergistic effects.
5-10 parts of manganese sulfate, which is an activator of various enzymes in a human body and has the functions of maintaining, protecting and repairing normal functions of pancreas. Long-term manganese deficiency can reduce the synthesis of insulin in human body, the utilization rate of glucose and the activity of superoxide dismutase in islet cells, thus causing sugar metabolism disorder and causing diabetes and cancer. The composition is used in combination with other plant-derived anti-liver cancer substances according to the formula principle, so that the whole medicament has strong, rapid and synergistic effects.
0.01-0.08 portion of penicillin sodium, which is one of antibiotics, refers to a class of antibiotics which contain penam in molecules extracted from penicillin culture solution, can destroy cell walls of bacteria and have the bactericidal effect in the propagation period of bacterial cells, and can sterilize and kill insects. The composition is used together with other plant-derived anti-cancer, cancer-preventing and cancer-curing substances according to the formula principle, so that the whole medicament has strong, rapid and synergistic effects.
TABLE 1 concrete case conditions
Figure BDA0002663000560000171
The patients 1-6 are diagnosed without operation, radiotherapy and chemotherapy, and can be cured by directly drinking the liquid composition, and after comprehensive physical examination, other indexes of the body are determined to be normal.
The application method of the broad-spectrum plant composition for curing and radically treating the liver cancer directly uses the prepared liquid matter of the broad-spectrum plant composition for curing and radically treating the liver cancer as a drink (prohibited for pregnant women). The liver cancer patient can cure the disease state radically after drinking the medicine in a daily dose of 4-6 ml to 6-8 months, and live a healthy life again.
The medicine adopts the principle of 'plant catenated' tetany 'cancer cell killing and limb simultaneous' five synchronous 'integrated refreshing cancer curing and radical cure therapy' to scientifically break through the bound bottleneck of the traditional Chinese medicine cancer curing theory and practice in clinical application practice, and open the subversive precedent that the new Chinese medicine field of the new era has the capability of efficiently curing and radical curing various types of cancers. The 'refreshment therapy' revolutionized the effect of cancer treatment and more revolutionized the concept of cancer treatment.
The medicine can be used for treating the same liver cancer, and because the cancer patients have different constitutions and disease conditions, the traditional Chinese medical doctors must make a unique formula and dosage constraint bottleneck for the liver cancer patients in a tailored manner, so that the invention subversively breaks through the problem that the traditional Chinese medical doctors draw pictures of the disease treatment images, each pen has a unique short plate defect, the disease treatment by using the medicine can also achieve the aim of taking pictures of the disease treatment images of the western medicine, and the used medicines have standardized scientific effects. "
The medicine has effects of promoting liver cancer patients to effectively recover and normalize the natural supply instinct of limbs, viscera and six hollow organs, eating, drinking, sleeping, excreting stool and urine, and invigorating energy.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any changes or substitutions that may be made by those skilled in the art within the technical scope of the present invention will be covered by the scope of the present invention.

Claims (9)

1. The broad-spectrum plant composition for curing and radically treating liver cancer is characterized in that: the composition comprises the following components in parts by weight: 38-68 parts of tripterygium wilfordii alkaloid; 38-68 parts of triptolide; 38-58 parts of chamaejasmine; 38-58 parts of gelsemine; 86-88 parts of honeysuckle chlorogenic acid; 80-88 parts of tanshinone; 80-88 parts of curcumin; 88-98 parts of paeoniflorin; 80-88 parts of adenophora tetraphylla bunge xanthotoxin; 80-88 parts of cooked rehmannia root; 80-88 parts of oriental wormwood flavone; 80-88 parts of rose volatile oil; 88-98 parts of silybum marianum organic acid; 88-98 parts of cyperus rotundus volatile oil; 80-88 parts of prunella vulgaris alkaloid; 80-88 parts of sculellaria barbata alkaloid; 80-88 parts of selaginella doederleinii alkaloid; 80-88 parts of chrysophanol; 80-90 parts of ganoderma lucidum polysaccharide; 68-88 parts of suberect spatholobus stem element; 45-68 parts of angelica volatile oil; 68-88 parts of fructus psoraleae volatile oil; 78-88 parts of astragalus saponin; 80-88 parts of elecampane inula root; 68-80 parts of aristolochin; 68-88 parts of areca peel alkaloid; 78-88 parts of achyranthes bidentata sterol; 80-88 parts of bighead atractylodes rhizome volatile oil; 80-90 parts of ophiopogon root glucose; 80-90 parts of yam germanium; 86-90 parts of semen cassiae emodin; 86-90 parts of tangerine peel flavone; 80-90 parts of lycium barbarum betaine; 80-88 parts of spora lygodii chlorogenic acid; 88-98 parts of notoginsenoside; 88-98 parts of costunolide; 80-90 parts of katsumade galangal seed volatile oil; 60-80 parts of cistanche minerals; 88-98 parts of toosendanin; 68-80 parts of morning glory seed glycosides; 80-88 parts of carthamin; 80-90 parts of paniculate swallowwort root propiophenone; 68-88 parts of long pepper volatile oil; 80-88 parts of fumaric acid; 80-88 parts of pachyman; 50-70 parts of pinellia ternate millet alcohol; 50-60 parts of lotus plumule alkaloid; 60-80 parts of broom cypress fruit alkaloid; 80-88 parts of omphalin; 78-88 parts of phytolaccagenin; 80-88 parts of folium artemisiae argyi essential oil cineole; 88-98 parts of polygonatum quinones; 80-88 parts of hawthorn flavone; 48-58 parts of sanshoamides; 80-88 parts of pueraria isoflavone; 60-80 parts of grape polymerized phenol; 85-98 parts of various trace elements of polygonum multiflorum; 150 portions of red date cyclic adenosine monophosphate and 250 portions of adenosine monophosphate; 0.4-0.8 part of folic acid; 68-88 parts of sophora flavescens alkaloids; 2-10 parts of copper sulfate; 10-16 parts of zinc sulfate; 5-10 parts of manganese sulfate; 0.01-0.08 part of penicillin sodium.
2. The broad-spectrum plant composition for curing and radically treating liver cancer according to claim 1, wherein the tripterygium alkaloid is an extract of dried root, stem, leaf of tripterygium wilfordii hook f, a Celastraceae plant; the Tripterygium wilfordii alkaloid comprises fixed alkali, increasernt, jin alkali, chun alkali and tositude, wherein the ratio of the fixed alkali to the increasernt to the jin alkali to the chun alkali to the tositude is 1:1:1:1: 1.
3. The broad-spectrum plant composition for curing and radically treating liver cancer according to claim 1, wherein the gelsemine is an extract of perennial green vine of the genus calamus of the family marchaniaceae, and contains a highly toxic component of the gelsemine.
4. The broad-spectrum plant composition for curing and radically treating liver cancer according to claim 3, wherein gelsemine is a liquid, paste or powder with a baume degree of 15-17 extracted by organic solvent or water decoction.
5. The broad-spectrum plant composition for curing and radically treating liver cancer according to claim 1, wherein the honeysuckle chlorogenic acid is an extract of a flower bud or a flower carried out from a flower bud of a perennial lonicera japonica plant of the family lonicera shrubbica, and contains chlorogenic acid components; is liquid or slurry or powder with Baume degree of 15-17 extracted by organic solvent or water boiling method.
6. The broad-spectrum plant composition for curing and radically treating liver cancer as claimed in claim 1, wherein the volatile oil of rose is an extract of dried flower buds of rose belonging to Rosaceae, and is composed of three components of volatile oils, namely nerol, citronellol and phenethyl alcohol.
7. The broad-spectrum plant composition for curing and radically curing liver cancer as claimed in claim 1, wherein said ganoderan is a dried fruiting body extract of Ganoderma lucidum karst or Ganoderma sinense of Polyporaceae, comprising ganoderan, L-mannitol and terpineol.
8. The broad-spectrum plant composition for curing and radically treating liver cancer according to claim 1, wherein the composition comprises the following components in parts by weight: 40 parts of tripterygium wilfordii alkaloid; 55 parts of triptolide; 40 parts of chamaejasmine; 45 parts of gelsemine; 86 parts of honeysuckle chlorogenic acid; 82 parts of tanshinone; 82 parts of curcumin; 90 parts of paeoniflorin; 82 parts of adenophora tetraphylla bunge xanthotoxin; 82 parts of cooked rehmannia root; 82 parts of oriental wormwood flavone; 86 parts of rose volatile oil; 90 parts of silybum marianum organic acid; 90 parts of cyperus rotundus volatile oil; 82 parts of prunella vulgaris alkaloid; 82 parts of sculellaria barbata alkaloid; 82 parts of selaginella doederleinii hieron alkaloid; 82 parts of chrysophanol; 88 parts of ganoderma lucidum polysaccharide; 70 parts of suberect spatholobus stem element; 50 parts of angelica volatile oil; 70 parts of fructus psoraleae volatile oil; 80 parts of astragalus saponin; 82 parts of elecampane inula root; 75 parts of aristolochia debilis alkali; 70 parts of areca peel alkaloid; 80 parts of achyranthes bidentata sterol; 82 parts of bighead atractylodes rhizome volatile oil; 82 parts of radix ophiopogonis glucose; 82 parts of yam germanium; 88 parts of semen cassiae emodin; 88 parts of dried orange peel flavone; 82 parts of lycium barbarum betaine; 82 parts of spora lygodii chlorogenic acid; 90 parts of notoginsenoside; 90 parts of costunolide; 82 parts of katsumade galangal seed volatile oil; 62 parts of cistanche minerals; 90 parts of toosendanin; 70 parts of morning glory seed glycosides; 82 parts of carthamin; 82 parts of paniculate swallowwort root propiophenone; 70 parts of long pepper volatile oil; 82 parts of fumaric acid; 82 parts of pachyman; 55 parts of pinellia ternate millet alcohol; 55 parts of lotus seed core alkaloid; 70 parts of broom cypress fruit alkaloid; 82 parts of omphalin; 80 parts of phytolaccagenin; 88 parts of argy wormwood leaf essential oil cineole; 90 parts of polygonatum quinones; 82 parts of hawthorn flavone; 50 parts of sanshoamides; 82 parts of pueraria isoflavone; 62 parts of grape polymerized phenol; 86 parts of various trace elements of polygonum multiflorum; 160 parts of red date cyclic adenosine monophosphate; 0.5 part of folic acid; 70 parts of sophora flavescens alkaloids; 4 parts of copper sulfate; 13 parts of zinc sulfate; 6 parts of manganese sulfate; penicillin sodium 0.02 portion.
9. A method for preparing the broad-spectrum plant composition for curing and radically treating liver cancer according to any one of claims 1 to 8,
step one, weighing medicinal materials: tripterygium wilfordii alkaloid, triptolide, chamaejasmine, gelsemium elegans, honeysuckle chlorogenic acid, tanshinone, curcumin, radix paeoniae alba paeoniflorin, adenophoral pricklyash peel toxin, cooked rehmannin, oriental wormwood flavone, rose volatile oil, silybum marianum organic acid, cyperus rotundus volatile oil, selfheal alkaloid, barbed skullcap herb alkaloid, selaginella tamariscina alkaloid, chrysophanol, ganoderan, suberect spatholobus stem element, Chinese angelica volatile oil, malaytea scurfpea fruit volatile oil, astragaloside, elecampane, aristolochia cochinchinensis, areca peel alkaloid, achyranthes bidentata sterol, bighead atractylodes rhizome volatile oil, ophiopogon glucose, yam germanium, cassia seed emodin, dried orange peel flavone, medlar betaine, climbing fern chloranthus glaber, notoginsenoside, costunolide, katsumadai galangal volatile oil, cistanche mineral matter, toosendan, morning glory glycoside, carthamin, pachyman, pinellia tuber millet alcohol, lotus plumule alkaloid, broom cypress fruit alkaloid, omphalin, phytolaccagenin, folium artemisiae argyi essential oil cineole, polygonatum quinones, hawthorn flavone, xanthoxylin, pueraria isoflavone, grape polymerized phenol, a plurality of microelements of polygonum multiflorum, red date cyclic phosphorus garlic adenosine, folic acid, sophora flavescens alkaloid, copper sulfate, zinc sulfate, manganese sulfate and penicillin sodium;
and step two, dissolving the medicines in water, and uniformly mixing.
CN202010910278.8A 2020-09-02 2020-09-02 Broad-spectrum plant composition for curing and radically treating liver cancer and preparation method thereof Pending CN111973709A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010910278.8A CN111973709A (en) 2020-09-02 2020-09-02 Broad-spectrum plant composition for curing and radically treating liver cancer and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010910278.8A CN111973709A (en) 2020-09-02 2020-09-02 Broad-spectrum plant composition for curing and radically treating liver cancer and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111973709A true CN111973709A (en) 2020-11-24

Family

ID=73447385

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010910278.8A Pending CN111973709A (en) 2020-09-02 2020-09-02 Broad-spectrum plant composition for curing and radically treating liver cancer and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111973709A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118001276A (en) * 2024-01-25 2024-05-10 黑龙江中医药大学 Pharmaceutical composition for treating epilepsy and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105878829A (en) * 2016-04-13 2016-08-24 董伟 Traditional Chinese medicine composition for treating liver cancer
CN106310120A (en) * 2016-08-31 2017-01-11 陈爱红 Wide-spectrum traditional Chinese medicine composition water agent and preparation method thereof
CN106492177A (en) * 2016-12-15 2017-03-15 陈爱红 Chinese medicine composition for the treatment of intestinal cancer and diabetes and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105878829A (en) * 2016-04-13 2016-08-24 董伟 Traditional Chinese medicine composition for treating liver cancer
CN106310120A (en) * 2016-08-31 2017-01-11 陈爱红 Wide-spectrum traditional Chinese medicine composition water agent and preparation method thereof
CN106492177A (en) * 2016-12-15 2017-03-15 陈爱红 Chinese medicine composition for the treatment of intestinal cancer and diabetes and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118001276A (en) * 2024-01-25 2024-05-10 黑龙江中医药大学 Pharmaceutical composition for treating epilepsy and application thereof
CN118001276B (en) * 2024-01-25 2025-02-18 黑龙江中医药大学 A pharmaceutical composition for treating epilepsy and its use

Similar Documents

Publication Publication Date Title
CN102845745A (en) Dendrobium officinale health-care product
CN103961521A (en) Traditional Chinese medicine composition for treating aplastic anemia and preparation method
CN108524814A (en) A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose
CN111544543A (en) Composition with functions of clearing lung, relieving tobacco toxicity, dispelling effects of alcohol and benefiting liver
CN108478731A (en) Chinese medicine preparation and Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease
CN104161977B (en) It is a kind of to be used to prevent and treat Chinese medicine composition of infectious coryza of chicken and preparation method thereof
CN111617206A (en) Plant preparation composition for treating lung cancer and preparation method and using method thereof
CN111973709A (en) Broad-spectrum plant composition for curing and radically treating liver cancer and preparation method thereof
KR102164421B1 (en) Herbal medicinal compositions for maintaining bone and muscle health, including meal worm, and method for producing the same
CN104208339A (en) Traditional Chinese medicine composition for treating livestock and poultry bacterial or viral diseases and preparation method thereof
CN115969909B (en) Traditional Chinese medicine composition and fermented traditional Chinese medicine preparation for improving sub-health of sow as well as preparation method and application of traditional Chinese medicine composition and fermented traditional Chinese medicine preparation
CN101474356A (en) Chinese medicine granular formulation for treating spinal cord and relevant diseases
CN108783432A (en) Health food and preparation method thereof with antitumaous effect
CN113209194B (en) Composition for treating chronic gastritis and preparation method and application thereof
CN101342249A (en) Chinese medicine formulations for treating hepatitis B and preparation method thereof
CN108434304A (en) The preparation method of cancer-resisting Chinese medicine
CN113812614A (en) Uric acid resistant functional food
CN107581153A (en) A kind of method of black bottom soft-shelled turtle ecologic breeding
CN1840036A (en) Chinese medicinal composite preparation capable of inhibiting growth of tumor cell
CN105853901A (en) Preparation for cancer patients to take during radiotherapy and chemotherapy, and method for preparing preparation
CN105561098A (en) Medicine for treating erosive beriberi
CN104984141A (en) Prescription for treating constipation and preparation method thereof
CN110522798A (en) A kind of compound preparation and preparation method thereof curing mainly coronary heart disease
CN105232958A (en) Traditional Chinese medicine combination for preparing medicine for treating myasthenia gravis
CN105597011A (en) Method for preparing traditional Chinese medicine composition for treating acute or chronic rhinitis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20201124